BG Medicine underwriters exercise over-allotment option in full

BG Medicine (NASDAQ: BGMD) today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 750,000 shares of BG Medicine's common stock at $7.00 per share, less underwriting discounts and commissions. BG Medicine also announced that it has closed its initial public offering of 5,750,000 shares of common stock at a public offering price of $7.00 per share, which included the sale of the shares pursuant to the over-allotment option.

Lazard Capital Markets LLC acted as the sole bookrunning manager for the initial public offering, and Baird and Cowen and Company acted as co-managers.

A registration statement relating to the offering was declared effective by the Securities and Exchange Commission on February 3, 2011. The offering was made solely by means of a written prospectus, copies of which may be obtained from Lazard Capital Markets LLC by mail at 30 Rockefeller Plaza, 60th Floor, New York, NY 10020, Attention: Syndicate Department, or by calling toll-free (800) 542-0970.